Equilis Prequenza, Suspension for Injection, for Horses

Horses:
Rare
(1 to 10 animals / 10,000 animals
treated):
Injection site swelling
, Injection site
pain
.
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Fever
, Lethargy
, Inappetence
,
Hypersensitivity reaction
.
A diffuse hard or soft swelling (max. diameter 5 cm), regressing within 2 days. A local reaction
exceeding 5 cm and possibly persisting longer than 2 days may occur in very rare cases.
Pain at the injection site may result in temporary functional discomfort (stiffness).
Fever, sometimes accompanied by lethargy and inappetence, may occur for 1 day, and up to
3 days in exceptional circumstances.
Including anaphylaxis (sometimes fatal). If such a reaction occurs, appropriate treatment
should be administered without delay.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See also the package leaflet for respective contact details.